UTHR in the 13F filings
United Therapeutics Corp Del · CUSIP 91307C102
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Feb 2026
- latest of these filings; the earliest 13 Nov 2025
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 10 listed it in both
- Shares listed
- 6,181,532
- combined, among listed positions
- Reported value
- $2.6bn
- combined, at the quarter end
Among the 95 comparable managers: 8 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing UTHR in Q3 2025
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 454,718 shares now+173,195
- Point72 Asset Management LPnew position · 99,784 shares now+99,784
- Renaissance Technologies LLCexisting position · 2,173,392 shares now+54,300
- ExodusPoint Capital Management LPnew position · 34,219 shares now+34,219
- Winton Group Ltdnew position · 21,109 shares now+21,109
Reductions
- AQR Capital Management LLCexisting position · 986,478 shares now-286,683
- Bridgewater Associates LPexisting position · 16,065 shares now-179,053
- Arrowstreet Capital LPexisting position · 208,535 shares now-130,557
- Acadian Asset Management LLCexisting position · 139,857 shares now-66,161
- Wellington Management Group LLPexisting position · 1,398,781 shares now-44,155
New positions and exits
New (3)
Exited (2)
- Marshall Wace LLPwas $79m
- Farallon Capital Management LLCwas $287k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 5 | $378m | n.a. | n.a. |
| Q3 2013 | 5 | $587m | n.a. | n.a. |
| Q4 2013 | 9 | $1.1bn | n.a. | n.a. |
| Q1 2014 | 8 | $923m | n.a. | n.a. |
| Q2 2014 | 9 | $716m | n.a. | n.a. |
| Q3 2014 | 11 | $1.1bn | n.a. | n.a. |
| Q4 2014 | 10 | $1.2bn | n.a. | n.a. |
| Q1 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q2 2015 | 14 | $1.6bn | n.a. | n.a. |
| Q3 2015 | 16 | $1.3bn | n.a. | n.a. |
| Q4 2015 | 16 | $1.6bn | n.a. | n.a. |
| Q1 2016 | 17 | $1.1bn | n.a. | n.a. |
| Q2 2016 | 12 | $869m | n.a. | n.a. |
| Q3 2016 | 14 | $1.0bn | n.a. | n.a. |
| Q4 2016 | 10 | $1.1bn | n.a. | n.a. |
| Q1 2017 | 13 | $1.1bn | n.a. | n.a. |
| Q2 2017 | 12 | $1.2bn | n.a. | n.a. |
| Q3 2017 | 8 | $1.1bn | n.a. | n.a. |
| Q4 2017 | 10 | $1.4bn | n.a. | n.a. |
| Q1 2018 | 8 | $1.0bn | n.a. | n.a. |
| Q2 2018 | 10 | $996m | n.a. | n.a. |
| Q3 2018 | 9 | $1.1bn | n.a. | n.a. |
| Q4 2018 | 9 | $1.0bn | n.a. | n.a. |
| Q1 2019 | 9 | $1.1bn | n.a. | n.a. |
| Q2 2019 | 15 | $804m | n.a. | n.a. |
| Q3 2019 | 17 | $913m | n.a. | n.a. |
| Q4 2019 | 14 | $863m | n.a. | n.a. |
| Q1 2020 | 14 | $1.2bn | n.a. | n.a. |
| Q2 2020 | 14 | $1.4bn | n.a. | n.a. |
| Q3 2020 | 10 | $797m | n.a. | n.a. |
| Q4 2020 | 11 | $1.2bn | n.a. | n.a. |
| Q1 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 11 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 16 | $1.5bn | n.a. | n.a. |
| Q4 2021 | 14 | $1.9bn | n.a. | n.a. |
| Q1 2022 | 14 | $1.7bn | n.a. | n.a. |
| Q2 2022 | 18 | $2.3bn | n.a. | n.a. |
| Q3 2022 | 17 | $2.2bn | n.a. | n.a. |
| Q4 2022 | 18 | $2.9bn | n.a. | n.a. |
| Q1 2023 | 16 | $2.5bn | n.a. | n.a. |
| Q2 2023 | 12 | $2.5bn | n.a. | n.a. |
| Q3 2023 | 13 | $2.4bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.3bn | 8 | 6 |
| Q1 2024 | 19 | $2.2bn | 14 | 6 |
| Q2 2024 | 14 | $2.5bn | 8 | 7 |
| Q3 2024 | 10 | $2.9bn | 6 | 4 |
| Q4 2024 | 14 | $3.3bn | 8 | 4 |
| Q1 2025 | 14 | $2.1bn | 7 | 6 |
| Q2 2025 | 14 | $1.9bn | 9 | 5 |
| Q3 2025 | 16 | $2.6bn | 8 | 10 |
| Q4 2025 | 14 | $3.8bn | 17 | 20 |
| Q1 2026 | 18 | $5.1bn | 18 | 17 |
| Q2 2026 | 14 | $3.5bn | 19 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own UTHR, latest filings →Back to the 13F Explorer →